Direxion Daily S&P Biotech Bear 3X ETF
LABD
17 hedge funds and large institutions have $16.2M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
636% more call options, than puts
Call options by funds: $7.69M | Put options by funds: $1.04M
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
13% more funds holding
Funds holding: 15 → 17 (+2)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
44% less capital invested
Capital invested by funds: $28.7M → $16.2M (-$12.5M)
48.59% less ownership
Funds ownership: 88.95% → 40.36% (-49%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$4.55M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$954K |
| 3 |
Jane Street
New York
|
+$431K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$374K |
| 5 |
HT
Headlands Technologies
Chicago,
Illinois
|
+$354K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$16M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$5.81M |
| 3 |
Squarepoint
New York
|
-$534K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$389K |
| 5 |
GS
GTS Securities
Miami,
Florida
|
-$298K |
LABD Hedge Fund Activity: Q4 2024 in Review
17 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q4 2024, worth a combined $16.2M — down 44% from $28.7M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new LABD positions and 3 closed out — a net gain of 2 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Virtu Financial, adding an estimated $4.55M. The largest seller was HRT Financial, cutting an estimated $16M.
- 17 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q4 2024, up from 15 in Q3 2024.
- Funds reported $16.2M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q4 2024, down 44% quarter-over-quarter.
- 5 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q4 2024 and 3 closed out, a net change of +2 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q4 2024 was Virtu Financial, an estimated $4.55M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q4 2024 was HRT Financial, an estimated $16M sold.
Based on aggregated 13F filings for Q4 2024.